Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction : a Danish nationwide study. / Christensen, Daniel Molager; Schjerning, Anne-Marie; Smedegaard, Laerke; Charlot, Mette Gitz; Ravn, Pauline B.; Ruwald, Anne Christine; Fosbol, Emil; Kober, Lars; Torp-Pedersen, Christian; Schou, Morten; Gerds, Thomas; Gislason, Gunnar; Sehested, Thomas S. G.

I: European Heart Journal, Bind 44, Nr. 6, 2023, s. 488–498.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Christensen, DM, Schjerning, A-M, Smedegaard, L, Charlot, MG, Ravn, PB, Ruwald, AC, Fosbol, E, Kober, L, Torp-Pedersen, C, Schou, M, Gerds, T, Gislason, G & Sehested, TSG 2023, 'Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study', European Heart Journal, bind 44, nr. 6, s. 488–498. https://doi.org/10.1093/eurheartj/ehac667

APA

Christensen, D. M., Schjerning, A-M., Smedegaard, L., Charlot, M. G., Ravn, P. B., Ruwald, A. C., Fosbol, E., Kober, L., Torp-Pedersen, C., Schou, M., Gerds, T., Gislason, G., & Sehested, T. S. G. (2023). Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study. European Heart Journal, 44(6), 488–498. https://doi.org/10.1093/eurheartj/ehac667

Vancouver

Christensen DM, Schjerning A-M, Smedegaard L, Charlot MG, Ravn PB, Ruwald AC o.a. Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study. European Heart Journal. 2023;44(6):488–498. https://doi.org/10.1093/eurheartj/ehac667

Author

Christensen, Daniel Molager ; Schjerning, Anne-Marie ; Smedegaard, Laerke ; Charlot, Mette Gitz ; Ravn, Pauline B. ; Ruwald, Anne Christine ; Fosbol, Emil ; Kober, Lars ; Torp-Pedersen, Christian ; Schou, Morten ; Gerds, Thomas ; Gislason, Gunnar ; Sehested, Thomas S. G. / Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction : a Danish nationwide study. I: European Heart Journal. 2023 ; Bind 44, Nr. 6. s. 488–498.

Bibtex

@article{cd3f5ddf5aaa42b49f2cc6a7de40d272,
title = "Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study",
abstract = "Aims Outcomes after myocardial infarction (MI) improved during recent decades alongside better risk factor management and implementation of guideline-recommended treatments. However, it is unknown whether this applies to stable patients who are event-free 1 year after MI. Methods and results Using nationwide Danish registries, we included all patients with first-time MI during 2000-17 who survived 1 year free from bleeding and cardiovascular events (n = 82 108, median age 64 years, 68.2% male). Follow-up started 1 year after MI and continued through January 2022. Crude risks of mortality, cardiovascular events, and bleeding were estimated in consecutive 3-year periods. Standardized risks were calculated with respect to the distribution of age, sex, comorbidities, and treatments in the latter period. Guideline-recommended treatment use increased during the study period: e.g. statins (68.6-92.5%) and percutaneous coronary intervention (23.9-68.2%). The crude 5-year risks of outcomes decreased (all P-trend",
keywords = "myocardial infarction stable, Guidelines, long-term risk, Registry, outcomes, DUAL ANTIPLATELET THERAPY, FIBRINOLYTIC THERAPY, FOCUSED UPDATE, TASK-FORCE, 2017 ESC, ELEVATION, ASSOCIATION, MANAGEMENT, DISEASE, RISK",
author = "Christensen, {Daniel Molager} and Anne-Marie Schjerning and Laerke Smedegaard and Charlot, {Mette Gitz} and Ravn, {Pauline B.} and Ruwald, {Anne Christine} and Emil Fosbol and Lars Kober and Christian Torp-Pedersen and Morten Schou and Thomas Gerds and Gunnar Gislason and Sehested, {Thomas S. G.}",
year = "2023",
doi = "10.1093/eurheartj/ehac667",
language = "English",
volume = "44",
pages = "488–498",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "6",

}

RIS

TY - JOUR

T1 - Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction

T2 - a Danish nationwide study

AU - Christensen, Daniel Molager

AU - Schjerning, Anne-Marie

AU - Smedegaard, Laerke

AU - Charlot, Mette Gitz

AU - Ravn, Pauline B.

AU - Ruwald, Anne Christine

AU - Fosbol, Emil

AU - Kober, Lars

AU - Torp-Pedersen, Christian

AU - Schou, Morten

AU - Gerds, Thomas

AU - Gislason, Gunnar

AU - Sehested, Thomas S. G.

PY - 2023

Y1 - 2023

N2 - Aims Outcomes after myocardial infarction (MI) improved during recent decades alongside better risk factor management and implementation of guideline-recommended treatments. However, it is unknown whether this applies to stable patients who are event-free 1 year after MI. Methods and results Using nationwide Danish registries, we included all patients with first-time MI during 2000-17 who survived 1 year free from bleeding and cardiovascular events (n = 82 108, median age 64 years, 68.2% male). Follow-up started 1 year after MI and continued through January 2022. Crude risks of mortality, cardiovascular events, and bleeding were estimated in consecutive 3-year periods. Standardized risks were calculated with respect to the distribution of age, sex, comorbidities, and treatments in the latter period. Guideline-recommended treatment use increased during the study period: e.g. statins (68.6-92.5%) and percutaneous coronary intervention (23.9-68.2%). The crude 5-year risks of outcomes decreased (all P-trend

AB - Aims Outcomes after myocardial infarction (MI) improved during recent decades alongside better risk factor management and implementation of guideline-recommended treatments. However, it is unknown whether this applies to stable patients who are event-free 1 year after MI. Methods and results Using nationwide Danish registries, we included all patients with first-time MI during 2000-17 who survived 1 year free from bleeding and cardiovascular events (n = 82 108, median age 64 years, 68.2% male). Follow-up started 1 year after MI and continued through January 2022. Crude risks of mortality, cardiovascular events, and bleeding were estimated in consecutive 3-year periods. Standardized risks were calculated with respect to the distribution of age, sex, comorbidities, and treatments in the latter period. Guideline-recommended treatment use increased during the study period: e.g. statins (68.6-92.5%) and percutaneous coronary intervention (23.9-68.2%). The crude 5-year risks of outcomes decreased (all P-trend

KW - myocardial infarction stable

KW - Guidelines

KW - long-term risk

KW - Registry

KW - outcomes

KW - DUAL ANTIPLATELET THERAPY

KW - FIBRINOLYTIC THERAPY

KW - FOCUSED UPDATE

KW - TASK-FORCE

KW - 2017 ESC

KW - ELEVATION

KW - ASSOCIATION

KW - MANAGEMENT

KW - DISEASE

KW - RISK

U2 - 10.1093/eurheartj/ehac667

DO - 10.1093/eurheartj/ehac667

M3 - Journal article

C2 - 36433809

VL - 44

SP - 488

EP - 498

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 6

ER -

ID: 328728887